title: Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatment.
authors: Giuseppe
authors: G
authors: Tagariello
authors: Roberto
authors: R
authors: Sartori
authors: Paolo
authors: P
authors: Radossi
authors: Nilla
authors: N
authors: Maschio
authors: Renzo
authors: R
authors: Risato
authors: Roberto
authors: R
authors: Stasi
mesh_terms: D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D012720:Severity of Illness Index; D013926:Thrombopoietin / Q000008:administration & dosage*
chemical_list: D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim